nonfatal MI, I 2 = 0%, HR 0.82, 95 CI% (0.68, 0.99), p = 0.043]
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be offered as chronic treatment along with lifestyle modifications to patients with obesity when the potential benefits outweigh the risks
Proprietary blends allow manufacturers to list ingredients without revealing quantities
Most people regain weight once they stop because the bodys natural GLP-1 rhythm remains weak
Rare but serious reactions include chest pain, irregular heartbeat, or paradoxical bronchospasm (worsening wheeze), all of which require immediate medical attention
IGF-1 rose markedly, but most functional-performance endpoints did not improve, and the trial was terminated early for a safety signal (see below)